Rockwell Medical, Inc. (RMTI) stock
RMTINasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 11/3081% below fair value
$6.10−0.51 (-7.72%)
Close on Nov 18, 2026Market cap $24.59MP/E –Yield –
Rockwell Medical total assets
Total assets on the balance sheet at the end of each period.
Rockwell Medical's total assets was $56.53M at Jun 30, 2026. For fiscal 2025 it was $57.15M, down 3.5% from the year before. Over ten years it grew -4.2% a year on average. The highest annual figure on record is $98.00M in fiscal 2014.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $57.15M | -3.5% |
| FY2024 | Dec 31, 2024 | $59.21M | +13.5% |
| FY2023 | Dec 31, 2023 | $52.17M | +11.9% |
| FY2022 | Dec 31, 2022 | $46.64M | -4.0% |
| FY2021 | Dec 31, 2021 | $48.57M | -37.5% |
| FY2020 | Dec 31, 2020 | $77.75M | +75.4% |
| FY2019 | Dec 31, 2019 | $44.32M | -15.7% |
| FY2018 | Dec 31, 2018 | $52.56M | -10.6% |
| FY2017 | Dec 31, 2017 | $58.78M | -29.3% |
| FY2016 | Dec 31, 2016 | $83.15M | -5.3% |
| FY2015 | Dec 31, 2015 | $87.82M | -10.4% |
| FY2014 | Dec 31, 2014 | $98.00M | +169.5% |
| FY2013 | Dec 31, 2013 | $36.36M | +113.6% |
| FY2012 | Dec 31, 2012 | $17.03M | -46.7% |
| FY2011 | Dec 31, 2011 | $31.94M | -13.6% |
| FY2010 | Dec 31, 2010 | $36.97M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $56.53M | +7.4% |
| Q1 FY2026 | Mar 31, 2026 | $57.42M | +6.4% |
| Q4 FY2025 | Dec 31, 2025 | $57.15M | -3.5% |
| Q3 FY2025 | Sep 30, 2025 | $57.49M | +0.7% |
| Q2 FY2025 | Jun 30, 2025 | $52.63M | -0.8% |
| Q1 FY2025 | Mar 31, 2025 | $53.96M | +6.4% |
| Q4 FY2024 | Dec 31, 2024 | $59.21M | +13.5% |
| Q3 FY2024 | Sep 30, 2024 | $57.08M | +8.5% |
| Q2 FY2024 | Jun 30, 2024 | $53.03M | +39.4% |
| Q1 FY2024 | Mar 31, 2024 | $50.72M | +25.3% |
| Q4 FY2023 | Dec 31, 2023 | $52.17M | +11.9% |
| Q3 FY2023 | Sep 30, 2023 | $52.61M | -2.9% |
| Q2 FY2023 | Jun 30, 2023 | $38.04M | -35.7% |
| Q1 FY2023 | Mar 31, 2023 | $40.47M | +8.1% |
| Q4 FY2022 | Dec 31, 2022 | $46.64M | -4.0% |
| Q3 FY2022 | Sep 30, 2022 | $54.19M | -7.7% |
| Q2 FY2022 | Jun 30, 2022 | $59.12M | -7.2% |
| Q1 FY2022 | Mar 31, 2022 | $37.44M | -46.1% |
| Q4 FY2021 | Dec 31, 2021 | $48.57M | -37.5% |
| Q3 FY2021 | Sep 30, 2021 | $58.70M | -31.1% |
| Q2 FY2021 | Jun 30, 2021 | $63.68M | +8.7% |
| Q1 FY2021 | Mar 31, 2021 | $69.45M | +3.9% |
| Q4 FY2020 | Dec 31, 2020 | $77.75M | +75.4% |
| Q3 FY2020 | Sep 30, 2020 | $85.24M | +77.3% |
| Q2 FY2020 | Jun 30, 2020 | $58.58M | +2.6% |
| Q1 FY2020 | Mar 31, 2020 | $66.83M | +37.1% |
| Q4 FY2019 | Dec 31, 2019 | $44.32M | -15.7% |
| Q3 FY2019 | Sep 30, 2019 | $48.09M | +26.3% |
| Q2 FY2019 | Jun 30, 2019 | $57.08M | +37.8% |
| Q1 FY2019 | Mar 31, 2019 | $48.75M | -4.8% |
| Q4 FY2018 | Dec 31, 2018 | $52.56M | -10.6% |
| Q3 FY2018 | Sep 30, 2018 | $38.08M | -42.1% |
| Q2 FY2018 | Jun 30, 2018 | $41.42M | -40.4% |
| Q1 FY2018 | Mar 31, 2018 | $51.21M | -36.4% |
| Q4 FY2017 | Dec 31, 2017 | $58.78M | -29.3% |
| Q3 FY2017 | Sep 30, 2017 | $65.81M | -20.6% |
| Q2 FY2017 | Jun 30, 2017 | $69.48M | – |
| Q1 FY2017 | Mar 31, 2017 | $80.46M | – |
| Q4 FY2016 | Dec 31, 2016 | $83.15M | – |
| Q3 FY2016 | Sep 30, 2016 | $82.85M | – |
See a number that looks wrong?